In its upcoming report, UnitedHealth Group (UNH) is predicted by Wall Street analysts to post quarterly earnings of $6.68 per share, reflecting an increase of 8.8% compared to the same period last year. Revenues are forecasted to be $98.95 billion, representing a year-over-year increase of 6.5%. Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe. Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock. While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights. With that in mind, let's delve into the average projections of some UnitedHealth metrics that are commonly tracked and projected by analysts on Wall Street. Based on the collective assessment of analysts, 'Revenues- Products' should arrive at $11.65 billion. The estimate indicates a change of +9.3% from the prior-year quarter. Analysts forecast 'Revenues- Services' to reach $9.25 billion. The estimate suggests a change of +6.8% year over year. The collective assessment of analysts points to an estimated 'Revenues- Investment and other income' of $1.04 billion. The estimate indicates a year-over-year change of -6.6%. Analysts predict that the 'Revenues- Premiums' will reach $77.04 billion. The estimate points to a change of +6.3% from the year-ago quarter. The average prediction of analysts places 'Operating Statistics - Medical Care Ratio' at 84.2%. Compared to the current estimate, the company reported 83.2% in the same quarter of the previous year. Analysts' assessment points toward 'Customers - UnitedHealthcare - Total Commercial' reaching 29,083.36 thousand. Compared to the present estimate, the company reported 27,175 thousand in the same quarter last year. Analysts expect 'Customers - UnitedHealthcare - Commercial- Risk-based' to come in at 8,482.20 thousand. Compared to the current estimate, the company reported 8,035 thousand in the same quarter of the previous year. The combined assessment of analysts suggests that 'Customers - UnitedHealthcare - Commercial- Fee-based' will likely reach 20,561.16 thousand. The estimate is in contrast to the year-ago figure of 19,140 thousand. The consensus estimate for 'Customers - UnitedHealthcare - Total Community and Senior' stands at 19,797.53 thousand. Compared to the present estimate, the company reported 20,275 thousand in the same quarter last year. It is projected by analysts that the 'Customers - UnitedHealthcare - Community and Senior - Medicare Advantage' will reach 7,866.97 thousand. Compared to the present estimate, the company reported 7,590 thousand in the same quarter last year. The consensus among analysts is that 'Customers - UnitedHealthcare - Community and Senior - Medicare Supplement (Standardized)' will reach 4,310.15 thousand. Compared to the current estimate, the company reported 4,330 thousand in the same quarter of the previous year. According to the collective judgment of analysts, 'Customers - UnitedHealthcare - Medicare Part D stand-alone' should come in at 3,106.38 thousand. The estimate compares to the year-ago value of 3,355 thousand. View all Key Company Metrics for UnitedHealth here>>> Over the past month, shares of UnitedHealth have returned +1.6% versus the Zacks S&P 500 composite's +5.1% change. Currently, UNH carries a Zacks Rank #3 (Hold), suggesting that its performance may align with the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Stay Ahead of the Game With UnitedHealth (UNH) Q2 Earnings: Wall Street's Insights on Key Metrics
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...